This inventor holds 8 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: N.v. Organon, Merck Sharp + Dohme B.v., Msd Oss B.v.. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010-2013
Title: The Innovations of Gerardus Johannes Kemperman
Introduction
Gerardus Johannes Kemperman is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of chemistry, particularly in the development of novel amino acid derivatives and processes for pharmaceutical applications. With a total of eight patents to his name, Kemperman has established himself as a key figure in his area of expertise.
Latest Patents
Kemperman's latest patents include innovative processes for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino-[4,5-c]pyrrole. This compound is crucial in the synthesis of asenapine, a medication used in the treatment of psychiatric disorders. His work not only focuses on the final product but also on the intermediate products necessary for these processes.
Career Highlights
Throughout his career, Kemperman has worked with prominent companies, including N.V. Organon. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas, leading to the successful patenting of his inventions.
Collaborations
Kemperman has collaborated with several professionals in his field, including Jacobus Johannes Maria Van Der Linden and Michael R Reeder. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Gerardus Johannes Kemperman is a distinguished inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations highlight his dedication to advancing chemical processes and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile